Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinosarcoma × Gemcitabine × Sarcoma × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 54 Leiomyosarcoma 15 Osteosarcoma 14 Neoplasm Metastasis 8 Breast Neoplasms 8 Pancreatic Neoplasms 7 Bone Neoplasms 7 Small Cell Lung Carcinoma 5 Rhabdomyosarcoma 5 Ovarian Neoplasms 5 Neoplasms 5 Liposarcoma 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Sarcoma, Synovial 4 Sarcoma, Ewing 4 Prostatic Neoplasms 4 Histiocytoma, Malignant Fibrous 4 Hemangiosarcoma 4 Colonic Neoplasms 4 Chondrosarcoma 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Melanoma 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Dermatofibrosarcoma 3 Uterine Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2

Interventions

Specimen Handling 8 Paclitaxel 6 Magnetic Resonance Spectroscopy 6 Nivolumab 5 Carboplatin 5 Biopsy 5 pembrolizumab 3 X-Rays 3 olaparib 2 ceralasertib 2 Taxes 2 trastuzumab deruxtecan 1 sargramostim 1 rucaparib 1 ribociclib 1 pelcitoclax 1 pazopanib 1 pamiparib 1 durvalumab 1 cobimetinib 1 cediranib 1 cabozantinib 1 belinostat 1 atezolizumab 1 apatinib 1 Trabectedin 1 Tissue Banks 1 TIC10 compound 1 Radiation 1 Phantoms, Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02203760 2024-11-15

PazoDoble

North Eastern German Society of Gynaecological Oncology

Phase 2 Active not recruiting

Carcinosarcoma, Leiomyosarcoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡